uniQure QURE
NASDAQ QURE
$44.50 -0.36 (-0.80%)
As of: Sep 4, 2026 · 3:59 PM EDT

uniQure (QURE) Cash & Equivalents (2015 - 2026)

uniQure (QURE) posted quarterly Cash & Equivalents of $413.0 million for Q2 2026, up 62.75% year-over-year from $253.8 million in Q2 2025, and up 195.03% quarter-over-quarter from $140.0 million in Q1 2026.

Analysis

uniQure (QURE) Cash & Equivalents (2015 - 2026) Analysis & Trends

uniQure's Cash & Equivalents history runs 12 years deep, the most recent figure standing at $413.0 million for Q2 2026.

  • In Q2 2026, Cash & Equivalents rose 62.75% year-over-year to $413.0 million; the TTM figure through Jun 2026 stood at $413.0 million (up 62.75% YoY), while the FY2025 annual figure was $80.2 million, down 49.51% from the prior year.
  • Cash & Equivalents for Q2 2026 stood at $413.0 million, up from $140.0 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $597.1 million in Q3 2025, with the low at $80.2 million in Q4 2025.
  • The 5-year median for Cash & Equivalents is $247.3 million (2024), against an average of $304.2 million.
  • The sharpest annual moves came in 2023 and 2025: Cash & Equivalents slumped 70.69% in 2023, then jumped 137.28% in 2025.
  • uniQure's Cash & Equivalents stood at $228.0 million in 2022, then climbed by 5.85% to $241.4 million in 2023, then plunged by 34.15% to $158.9 million in 2024, then plunged by 49.51% to $80.2 million in 2025, then soared by 414.74% to $413.0 million in 2026.
  • Business Quant data shows QURE's Cash & Equivalents at $413.0 million in Q2 2026, $140.0 million in Q1 2026, and $80.2 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 6.14 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.46 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 3.58 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 1.72 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 815.44 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.10 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.71 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 811.99 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 544.80 Mn
10 uniQure 2.95 Bn 2.95 Bn 5.49 Mn 413.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 413.03 Mn
Mar 31, 2026 139.99 Mn
Dec 31, 2025 80.24 Mn
Sep 30, 2025 597.06 Mn
Jun 30, 2025 253.78 Mn
Mar 31, 2025 217.23 Mn
Dec 31, 2024 158.93 Mn
Sep 30, 2024 251.63 Mn
Jun 30, 2024 287.88 Mn
Mar 31, 2024 243.06 Mn
Dec 31, 2023 241.36 Mn
Sep 30, 2023 229.48 Mn
Jun 30, 2023 513.60 Mn
Mar 31, 2023 153.85 Mn
Dec 31, 2022 228.01 Mn
Sep 30, 2022 440.31 Mn
Jun 30, 2022 500.52 Mn
Mar 31, 2022 524.89 Mn
Dec 31, 2021 556.26 Mn
Sep 30, 2021 578.46 Mn